BNET Industries

Market Cap:$147.6B
Last Fiscal Year Sales:$48.4B
- Public
- US
Dow Jones Description
Taking care of you and your four-legged friends too! Pfizer Inc. (NYSE: PFE), based in New York, NY, discovers, develops, manufactures and sells prescription medications for humans and animals. Employing about 115,000 people, this $51.3 billion company operates in three segments: Human Health, Consumer Healthcare and Animal Health. Together, these segments cover treatments for diseases such as cardiovascular and metabolic diseases, medications for oral care, tobacco dependence, and products for prevention and treatment of diseases in livestock and pets.
Number of Employees 81,800
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
A Dividend-Stock Holiday Shopping List
-
Pfizer whistleblower wins 2009 honor for business ethics: Complaint led to largest criminal fine in...
-
Week of Dec. 14, 2009: Company Notes: Sanofi Pasteur recalls H1N1 vaccine; Patheon consolidates Puerto...
-
Adimab Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two...
-
Adimab Announces New Antibody Discovery Collaborations and Achievement of Milestones in Two Existing Partnerships
-
Adimab Signs Deal with Pfizer
-
Susan Kim: Menopause: Marketing Fear
-
Takeda, Pfizer To Co-Promote Actos Type 2 Diabetes Drug In China - Update
-
Pfizer Raises Quarterly Dividend 13%, See More Annual Hikes
-
Pfizer Declares 1Q 2010 Cash Dividend
-
BRIEF: SEC probing insider-trading allegations
-
Pfizer joins partnership with Calif. firm: Collaboration planned with Crown Bioscience for cancer research
-
Research and Markets: The Future of Cardiovascular Diseases Therapeutics - Market Forecasts to...
-
Science and Technology: Pfizer to buy Croatian drug patent
-
Bristol-Myers Squibb Raises Exchange Offer Price For Mead Johnson Shares - Update
-
'IT boosts efficiency & innovation'
-
Inspector General Saved Billions in Healthcare This Year
-
Private security firms no longer able to provide police information checks
-
Reportlinker Adds Growth Factors Blood And Tissue - A World Report
News & Analysis
Filter by
investment and pfizer inc. - All News and Analysis
Pfizer Scientist Stabbed Wife After Job Loss, Police Say
A former Pfizer PFE employee who lost his job and “was convinced he could not provide for his family any further,†has been charged with stabbing his wife, according to police. Pfizer is in the process of laying off 19,500 employees in its merger with Wyeth. Asbill was involved in...
As Tax Breaks for Pfizer End, Jobs Disappear
As Pfizer PFE reorganizes after its merger with Wyeth, municipalities are finding that the tax deals they once struck to keep the drug giant in town are having short-term advantages at best and, at worst, no effect at all. Pfizer must make 19,500 layoffs across its empire to make the...
Pfizer's R&D Cuts Render Kelo v. New London Eminent Domain Case a Waste of Time
Pfizer PFE will close its New London, Conn., site and consolidate operations there at the nearby Groton, Conn., site in a swathe of R&D closures as the company seeks 19,500 job cuts in the wake of its merger with Wyeth. Pfizer's abandonment of its plans for New London render moot...
Pfizer Aiming for 30,900 Layoffs Through 2012
Pfizer has laid off 26,300 employees since 2005, and hopes eventually to lay off a total of 30,900 through 2012, according to its 10-Q filing with the SEC. The company had several rounds of layoffs before its acquisition of Wyeth in an attempt to get $6 billion in annual savings...
Pfizer Unveils Shiny New "Leaping" Logo
Pfizer PFE, fresh from consummating its merger with Wyeth WYE, has unveiled a new logo. Don't get too excited -- it looks a lot like the old logo. by Jim Edwards
Pfizer Q3: Healthy Profit Masks Revenue Decline
This merger with Wyeth can't come soon enough for Pfizer. The company's revenues were down 3 percent to $11.6 billion in Q3 2009, although net income was $2.8 billion up 26 percent. That healthy profit growth masks the reality of Pfizer's business: Of all its drugs, only four saw growth....
Pfizer Closes Bridgewater Site; Clock Ticks on CT Tax Deal; Layoffs All Over
As Pfizer decides how to cut 19,500 jobs in its merger with Wyeth, which closed today, the clock is ticking at its New London campus on a tax deal that gives the company an 80 percent reduction in its municipal bill. by Jim Edwards
Pfizer's Silence on Post-Wyeth Merger Job Cuts, Site Closures Has Everyone on Edge
Pfizer is driving everyone nuts with its silence on which sites, offices and labs it will close following its merger with Wyeth. Even the Connecticut governor doesn't know what Pfizer's plans will be, even though the state has two sites -- Groton and New London -- and 5,000 jobs at...
Pfizer Stock Shrugs Off $2.3B Bextra Fine; Can Anything Deter Off-Label Promotion?
Pfizer's $2.3 billion settlement with the government over its mismarketing of Bextra is significant, but a look at other liabilities and settlements suggests that stock prices are unaffected by government discipline of off-label marketing. by Jim Edwards
In Pfizer-Wyeth Merger Suit, It's Capitalism v. Socialism
The suit filed by various pharmacies to block the Pfizer-Wyeth merger is worth reading if you want to put in context the sheer size of the merger. It also delineates a faux conflict between the forces of capitalism pharmacies and socialism drug companies. by Jim Edwards
Industry Transcripts by Seeking Alpha
-
Neogen Corporation F2Q10 (Qtr End11/30/09) Earnings Call Transcript
on Dec 18, 2009about NEOG
-
Schiff Nutrition International, Inc. F2Q10 (Qtr End 11/30/09) Earnings Call Transcript
on Dec 17, 2009about WNI
-
Martek Biosciences Corporation F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 16, 2009about MATK
-
Peregrine Pharmaceuticals Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Dec 10, 2009about PPHM
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes

